Movatterモバイル変換


[0]ホーム

URL:


ATE553105T1 - Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer - Google Patents

Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer

Info

Publication number
ATE553105T1
ATE553105T1AT07866894TAT07866894TATE553105T1AT E553105 T1ATE553105 T1AT E553105T1AT 07866894 TAT07866894 TAT 07866894TAT 07866894 TAT07866894 TAT 07866894TAT E553105 T1ATE553105 T1AT E553105T1
Authority
AT
Austria
Prior art keywords
nucleosidase
compounds
ais
phosphorylase inhibitors
azetidine
Prior art date
Application number
AT07866894T
Other languages
English (en)
Inventor
Gary Brian Evans
Richard Hubert Furneaux
Ben William Greatrex
Vern L Schramm
Peter Charles Tyler
Original Assignee
Ind Res Ltd
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Res Ltd, Einstein Coll MedfiledCriticalInd Res Ltd
Application grantedgrantedCritical
Publication of ATE553105T1publicationCriticalpatent/ATE553105T1/de

Links

Classifications

Landscapes

AT07866894T2006-12-222007-12-21Azetidin-analoge ais nucleosidase- und phosphorylase-hemmerATE553105T1 (de)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US87694706P2006-12-222006-12-22
PCT/NZ2007/000387WO2008079028A1 (en)2006-12-222007-12-21Azetidine analogues of nucleosidase and phosphorylase inhibitors

Publications (1)

Publication NumberPublication Date
ATE553105T1true ATE553105T1 (de)2012-04-15

Family

ID=39562725

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AT07866894TATE553105T1 (de)2006-12-222007-12-21Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer

Country Status (14)

CountryLink
US (1)US8283345B2 (de)
EP (1)EP2114925B8 (de)
JP (1)JP2010513477A (de)
KR (1)KR20090101278A (de)
CN (1)CN101600711A (de)
AT (1)ATE553105T1 (de)
AU (1)AU2007338953A1 (de)
CA (1)CA2674525A1 (de)
CY (1)CY1112889T1 (de)
DK (1)DK2114925T3 (de)
ES (1)ES2385759T3 (de)
NZ (1)NZ577682A (de)
PT (1)PT2114925E (de)
WO (1)WO2008079028A1 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
PT1539783E (pt)*2002-08-212011-06-01Einstein Coll MedInibidores de nucleósido fosforilases e de nucleosidases
NZ523970A (en)*2003-02-042005-02-25Ind Res LtdProcess for preparing inhibitors of nucleoside phoshorylases and nucleosidases
NZ533360A (en)2004-06-042007-02-23Ind Res LtdImproved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
US9512125B2 (en)2004-11-192016-12-06The Regents Of The University Of CaliforniaSubstituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
US8541567B2 (en)2005-07-272013-09-24Albert Einstein College Of Medicine Of Yeshiva UniversityTransition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en)*2005-12-152008-07-31Ind Res LtdDeazapurine analogs of 1'-aza-l-nucleosides
WO2007097643A1 (en)2006-02-222007-08-30Industrial Research LimitedAnalogues of coformycin and their use for treating protozoan parasite infections
AU2007218334A1 (en)*2006-02-242007-08-30Albert Einstein College Of Medicine Of Yeshiva UniversityMethods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
US8916571B2 (en)2006-02-242014-12-23Albert Einstein College Of Medicine Of Yeshiva UniversityMethods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
ES2423010T3 (es)2006-04-042013-09-17The Regents Of The University Of CaliforniaDerivados de pirazolopirimidina para su uso como antagonistas de cinasa
AU2007293773B2 (en)*2006-09-072013-01-31Albert Einstein College Of Medicine, Inc.Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
KR101433621B1 (ko)2006-09-072014-08-27알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티누클레오시드 포스포릴라아제 및 히드롤라아제의 비고리형 아민 억제제
GB2467670B (en)2007-10-042012-08-01Intellikine IncChemical entities and therapeutic uses thereof
US8193182B2 (en)2008-01-042012-06-05Intellikine, Inc.Substituted isoquinolin-1(2H)-ones, and methods of use thereof
KR101660050B1 (ko)2008-01-042016-09-26인텔리카인, 엘엘씨특정 화학 물질, 조성물 및 방법
US8993580B2 (en)2008-03-142015-03-31Intellikine LlcBenzothiazole kinase inhibitors and methods of use
JP5547099B2 (ja)2008-03-142014-07-09インテリカイン, エルエルシーキナーゼ阻害剤および使用方法
US20110224223A1 (en)2008-07-082011-09-15The Regents Of The University Of California, A California CorporationMTOR Modulators and Uses Thereof
NZ590258A (en)2008-07-082013-10-25Intellikine LlcKinase inhibitors and methods of use
EP2348854A4 (de)2008-09-222012-03-14Einstein Coll MedVerfahren und zusammensetzungen für die behandlung von bakteriellen infektionen durch hemmung des »quorum sensing
CA2738429C (en)2008-09-262016-10-25Intellikine, Inc.Heterocyclic kinase inhibitors
EP2358720B1 (de)2008-10-162016-03-02The Regents of The University of CaliforniaHeteroarylkinasehemmer mit kondensierten ringen
US8476431B2 (en)2008-11-032013-07-02Itellikine LLCBenzoxazole kinase inhibitors and methods of use
GB0904287D0 (en)2009-03-122009-04-22Prosidion LtdCompounds for the treatment of metabolic disorders
CA2760791C (en)2009-05-072017-06-20Intellikine, Inc.Heterocyclic compounds and uses thereof
US9493465B2 (en)2009-07-172016-11-15Victoria Link Limited3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase
WO2011047384A2 (en)2009-10-162011-04-21The Regents Of The University Of CaliforniaMethods of inhibiting ire1
ES2593256T3 (es)2010-05-212016-12-07Infinity Pharmaceuticals, Inc.Compuestos químicos, composiciones y métodos para las modulaciones de cinasas
AU2011326427B2 (en)2010-11-102016-01-07Infinity Pharmaceuticals Inc.Heterocyclic compounds and uses thereof
WO2012074912A1 (en)2010-11-292012-06-07Albert Einstein College Of Medicine Of Yeshiva UniversityMethods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
NZ612909A (en)2011-01-102015-09-25Infinity Pharmaceuticals IncProcesses for preparing isoquinolinones and solid forms of isoquinolinones
CN103491962B (zh)2011-02-232016-10-12因特利凯有限责任公司激酶抑制剂的组合及其用途
WO2012150866A1 (en)*2011-05-032012-11-08Industrial Research LimitedPhosphoribosyltransferase inhibitors and uses thereof
CA2842190A1 (en)2011-07-192013-01-24Infinity Pharmaceuticals Inc.Heterocyclic compounds and uses thereof
EP2734520B1 (de)2011-07-192016-09-14Infinity Pharmaceuticals, Inc.Heterocyclische verbindungen und ihre verwendung
MX2014002542A (es)2011-08-292014-07-09Infinity Pharmaceuticals IncCompuestos heterociclicos y usos de los mismos.
CA2846496C (en)2011-09-022020-07-14The Regents Of The University Of CaliforniaSubstituted pyrazolo[3,4-d]pyrimidines and uses thereof
US8940742B2 (en)2012-04-102015-01-27Infinity Pharmaceuticals, Inc.Heterocyclic compounds and uses thereof
US8828998B2 (en)2012-06-252014-09-09Infinity Pharmaceuticals, Inc.Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
JP6063571B2 (ja)2012-08-072017-01-18アルバート アインシュタイン カレッジ オブ メディシン,インコーポレイティドヘリコバクター・ピロリ感染の治療
RU2015115631A (ru)2012-09-262016-11-20Дзе Риджентс Оф Дзе Юниверсити Оф КалифорнияМодулирование ire1
PL2914296T5 (pl)2012-11-012022-01-17Infinity Pharmaceuticals, Inc.Leczenie nowotworu z zastosowaniem modulatorów izoform kinazy PI3
US9481667B2 (en)2013-03-152016-11-01Infinity Pharmaceuticals, Inc.Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
US9452217B2 (en)2013-06-222016-09-27Nitor TherapeuticsMethods for potentiating immune response for the treatment of infectious diseases and cancer
WO2015051241A1 (en)2013-10-042015-04-09Infinity Pharmaceuticals, Inc.Heterocyclic compounds and uses thereof
PH12016500582B1 (en)2013-10-042023-06-30Infinity Pharmaceuticals IncHeterocyclic compounds and uses thereof
KR20160101162A (ko)2013-12-242016-08-24프레지던트 앤드 펠로우즈 오브 하바드 칼리지코르티스타틴 유사체 및 그의 합성 및 용도
SG11201606595RA (en)2014-02-122016-09-29Einstein Coll MedTreatment of h. pylori infections using mtan inhibitors
CN113616656B (zh)2014-03-192023-02-17无限药品股份有限公司用于治疗PI3K-γ介导的障碍的杂环化合物
WO2015160975A2 (en)2014-04-162015-10-22Infinity Pharmaceuticals, Inc.Combination therapies
WO2016054491A1 (en)2014-10-032016-04-07Infinity Pharmaceuticals, Inc.Heterocyclic compounds and uses thereof
WO2016182932A1 (en)2015-05-082016-11-17President And Fellows Of Harvard CollegeCortistatin analogues, syntheses, and uses thereof
WO2017004411A1 (en)2015-07-012017-01-05President And Fellows Of Harvard CollegeCortistatin analogues and syntheses and uses thereof
JP6980649B2 (ja)2015-09-142021-12-15インフィニティー ファーマシューティカルズ, インコーポレイテッドイソキノリノン誘導体の固体形態、それを製造する方法、それを含む組成物、及びそれを使用する方法
RU2018133138A (ru)*2016-02-192020-03-19Президент Энд Феллоус Оф Гарвард КолледжАналоги кортистатина
WO2017161116A1 (en)2016-03-172017-09-21Infinity Pharmaceuticals, Inc.Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en)2016-06-082017-12-14Infinity Pharmaceuticals, Inc.Heterocyclic compounds and uses thereof
IL263680B1 (en)2016-06-242025-06-01Infinity Pharmaceuticals IncPi3k inhibitors for use in combination with a second therapeutic agent in treating, managing, or preventing cancer
MX390277B (es)2016-08-312025-03-20Servier LabInhibidores de procesos metabolicos celulares.
CN108069889B (zh)*2016-11-102021-10-01上海西浦医药科技有限公司一种氮杂环丁烷-3-甲酸的合成方法
JP2023508978A (ja)*2019-12-232023-03-06サンフォード バーナム プレビス メディカル ディスカバリー インスティテュートエクトヌクレオチドピロホスファターゼ/ホスホジエステラーゼ1(enpp1)モジュレーター及びその使用
GB202218782D0 (en)2022-12-132023-01-25Mehrling ThomasPurine nucleoside phosphorylase inhibitor for metabolic syndrome
CN116478172B (zh)*2023-06-202023-09-05英矽智能科技(上海)有限公司吡咯并[3,2-d]嘧啶类化合物及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO1997031008A1 (en)*1996-02-231997-08-28Industrial Research LimitedEnzyme detection/assay method and substrates
GB9609374D0 (en)*1996-05-031996-07-10Merck Sharp & DohmeTherapeutic agents
US5985848A (en)*1997-10-141999-11-16Albert Einstein College Of Medicine Of Yeshiva UniversityInhibitors of nucleoside metabolism
TR200002466T2 (tr)*1998-02-262000-12-21Akzo Nobel N.V.Azetidin ve pirolidin türevleri
CA2368095C (en)*1999-04-082009-10-06Industrial Research LimitedProcess for preparing inhibitors of nucleoside metabolism
US6448799B1 (en)*1999-09-302002-09-10Hitachi Electronics Engineering Co., Ltd.Timing adjustment method and apparatus for semiconductor IC tester
US7109331B2 (en)*2000-08-292006-09-19Industrial Research Limited5H-pyrrolo[3,2-d]pyrimidine nucleoside metabolism inhibitors
US6458799B1 (en)2000-08-312002-10-01Biocryst Pharmaceuticals, Inc.Deazaguanine analog, preparation thereof and use thereof
US7098334B2 (en)*2002-03-252006-08-29Industrial Research Limited4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
PT1539783E (pt)*2002-08-212011-06-01Einstein Coll MedInibidores de nucleósido fosforilases e de nucleosidases
EP1569933B1 (de)*2002-12-132008-07-23SmithKline Beecham CorporationPyrrolidin- und azetidinverbindungen alsccr5-antagonisten
NZ523970A (en)*2003-02-042005-02-25Ind Res LtdProcess for preparing inhibitors of nucleoside phoshorylases and nucleosidases
JP2007504246A (ja)*2003-09-052007-03-01イェシバ・ユニバーシティチミジンホスホリラーゼの遷移状態構造および阻害剤
NZ533360A (en)2004-06-042007-02-23Ind Res LtdImproved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
JP2008508287A (ja)2004-07-272008-03-21バイオクリスト・フアーマシユーテイカルズ・インコーポレイテツド5’−メチルチオアデノシンホスホリラーゼ及び5’メチルチオアデノシン/s−アデノシルホモシステインヌクレオシダーゼの阻害剤
NZ540160A (en)2005-05-202008-03-28Einstein Coll MedInhibitors of nucleoside phosphorylases
US8541567B2 (en)2005-07-272013-09-24Albert Einstein College Of Medicine Of Yeshiva UniversityTransition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en)*2005-12-152008-07-31Ind Res LtdDeazapurine analogs of 1'-aza-l-nucleosides
AU2007218334A1 (en)2006-02-242007-08-30Albert Einstein College Of Medicine Of Yeshiva UniversityMethods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
US8916571B2 (en)*2006-02-242014-12-23Albert Einstein College Of Medicine Of Yeshiva UniversityMethods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
KR101433621B1 (ko)2006-09-072014-08-27알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티누클레오시드 포스포릴라아제 및 히드롤라아제의 비고리형 아민 억제제
AU2007293773B2 (en)2006-09-072013-01-31Albert Einstein College Of Medicine, Inc.Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
WO2008039324A1 (en)2006-09-262008-04-03Albert Einstein College Of Medicine Of Yeshiva UniversityTransition state structure of human 5'-methylthioadenosine phosphorylase
WO2009082247A1 (en)2007-12-212009-07-02Industrial Research LimitedProcess for preparing immucillins having a methylene link
EP2348854A4 (de)2008-09-222012-03-14Einstein Coll MedVerfahren und zusammensetzungen für die behandlung von bakteriellen infektionen durch hemmung des »quorum sensing
US9493465B2 (en)2009-07-172016-11-15Victoria Link Limited3-hydroxypyrrolidine inhibitors of 5′-methylthioadenosine phosphorylase and nucleosidase

Also Published As

Publication numberPublication date
EP2114925B8 (de)2013-04-10
US8283345B2 (en)2012-10-09
DK2114925T3 (da)2012-05-29
ES2385759T3 (es)2012-07-31
HK1138276A1 (en)2010-08-20
US20100168141A1 (en)2010-07-01
JP2010513477A (ja)2010-04-30
PT2114925E (pt)2012-05-29
CA2674525A1 (en)2008-07-03
AU2007338953A1 (en)2008-07-03
EP2114925A4 (de)2010-10-20
EP2114925A1 (de)2009-11-11
NZ577682A (en)2012-03-30
EP2114925B1 (de)2012-04-11
KR20090101278A (ko)2009-09-24
CY1112889T1 (el)2016-04-13
CN101600711A (zh)2009-12-09
WO2008079028A1 (en)2008-07-03

Similar Documents

PublicationPublication DateTitle
ATE553105T1 (de)Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer
EA200901138A1 (ru)Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
CL2008000670A1 (es)Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras.
BRPI0915084B8 (pt)composto, e, composição farmacêutica
UA100840C2 (ru)Композиция для лечения вирусного гепатита
MX2009006704A (es)Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
TW200716646A (en)(S)-N-methylnaltrexone
PH12014500053A1 (en)Proteasome inhibitors
NO20092637L (no)Fremgangsmater for behandling
NO20083501L (no)Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
NO20074823L (no)Rasagilin-formuleringer med forbedret innholdsensartethet
EA200901133A1 (ru)Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
CL2007003774A1 (es)Compuestos derivados de quinazolina sustituidos, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, aterosclerosis y artritis.
MX2009009591A (es)Aminopirimidinas utiles como inhibidores de proteinas cinasas.
CL2007000806A1 (es)Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer.
TW200738659A (en)Novel compounds
NO20090157L (no)Tienpyrimidiner anvendelige som modulatorer av ionekanaler
NO20073182L (no)Indazol-karboksamidforbindelser
TW200730518A (en)Crystalline forms of docetaxel and processes for their preparation
TW200724537A (en)Pyrimidine derivatives for treatment of hyperproliferative disorders
NO20070487L (no)3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO341679B1 (no)Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
TW200606162A (en)Pyrazolopyridine derivatives
DE602007010764D1 (en)Benzamidglucokinaseaktivatoren
TW200745122A (en)New compounds I

[8]ページ先頭

©2009-2025 Movatter.jp